4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) is highlighted as one of the Best Get Rich Fast Stocks to Buy Right Now. Analysts give it a ‘Buy’ rating, with a median price target of $33, signaling over 300% potential upside. The company’s CLO recently sold shares worth $17,821. Positive clinical trial data for cystic fibrosis treatment was also reported.

In the recent clinical trial update, 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) showed promising results for its 4D-710 Phase 1 AEROW trial targeting cystic fibrosis lung disease. No new safety events were reported, and adverse events were mild and resolvable. The results demonstrated stable and dose-dependent CFTR transgene RNA levels.

Founded in 2013, 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) is a California-based biotech company specializing in adeno-associated virus vectors. The company’s proprietary Therapeutic Vector Evolution platform drives its operations. While FDMT shows investment potential, other AI stocks may offer greater upside and lower risk.

For those seeking investment opportunities, 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) presents a strong contender. The company’s recent clinical trial data and positive outlook make it an attractive option for investors. Additionally, its focus on adeno-associated virus vectors positions it well in the biotech market.

Read more at Yahoo Finance: Why Everyone Is Watching 4D Molecular Therapeutics, Inc. (FDMT) Closely